Show source-provided references
2. Migliori, G.B., Tiber, I.S., Zumla, A., Petersen, E., Chakaya, J.M., Wejse, C., Muñoz Torrico, M., Duarte, R., Alffenaar, J.W., and Members of the Global Tuberculosis Network (2020). MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network. Int. J. Infect. Dis., S1201-9712(20)30045-X.
5. World Health Organization (2019). Global Tuberculosis Report 2019, World Health Organization. Available online: https://apps.who.int/iris/bitstream/handle/10665/329368/9789241565714-eng.pdf?ua=1.
6. Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: A multicentre study
10.1183/13993003.00387-2017 ↗7. Members of the International Study Group on new anti-tuberculosis drugs and adverse events monitoring. Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study
10.1016/j.ijid.2019.03.036 ↗13. Reducing tuberculosis transmission: A consensus document from the World Health Organization Regional Office for Europe
10.1183/13993003.00391-2019 ↗14. Akkerman, O.W., Ter Beek, L., Centis, R., Maeurer, M., Visca, D., Muñoz-Torrico, M., Tiberi, S., and Migliori, G.B. (2020). Rehabilitation, optimized nutritional care, and boosting host internal milieu to improve long-term treatment outcomes in tuberculosis patients. Int. J. Infect. Dis., S1201-9712(20)30031-X.
10.1016/j.ijid.2020.01.029 ↗18. Surgical intervention in the treatment of pulmonary disease caused by drug resistant Mycobacterium tuberculosis
10.1164/ajrccm/141.3.623 ↗20. Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery
10.1016/j.jinf.2018.08.003 ↗22. The medical and surgical treatment of drug-resistant tuberculosis
26. Chen, G., Zhong, F.M., Xu, X.D., Yu, G.C., and Zhu, P.F. (2018). Efficacy of regional arterial embolization before pleuropulmonary resection in 32 patients with tuberculosis-destroyed lung. Bmc. Pulm. Med., 18.
10.1186/s12890-018-0722-5 ↗28. Surgical interventions for drug-resistant tuberculosis: A systematic review and metaanalysis
10.5588/ijtld.12.0198 ↗29. Pulmonary resection for patients with multidrug-resistant tuberculosis: Systematic review and meta-analysis
10.1093/jac/dkr210 ↗30. Johnston, J.C., Shahidi, N.C., Sadatsafavi, M., and Fitzgerald, J.M. (2009). Treatment outcomes of multidrug-resistant tuberculosis: A systematic review and meta-analysis. PLoS ONE, 4.
10.1371/journal.pone.0006914 ↗33. Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017, Ahmad, N., Ahuja, S.D., Akkerman, O.W., Alffenaar, J.C., Anderson, L.F., Baghaei, P., Bang, D., Barry, P.M., and Bastos, M.L. (2018). Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: An individual patient data meta-analysis. Lancet, 392, 821–834.
34. Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis
10.3201/eid2603.190997 ↗35. Surgery as an Adjunctive Treatment for Multidrug-Resistant Tuberculosis: An Individual Patient Data Metaanalysis
10.1093/cid/ciw002 ↗36. World Health Organization (2019). WHO Consolidated Guidelines on Drug-Resistant Tuberculosis Treatment, World Health Organization. Available online: https://apps.who.int/iris/bitstream/handle/10665/311389/9789241550529-eng.pdf?ua=1.
37. World Health Organization Regional Office for Europe (2014). The Role of Surgery in the Treatment of Pulmonary TB and Multidrug and Extensively Drug-Resistant TB, WHO Regional Office for Europe. Available online: http://www.euro.who.int/__data/assets/pdf_file/0005/259691/The-role-of-surgery-in-the-treatment-of-pulmonary-TB-and-multidrug-and-extensively-drug-resistant-TB.pdf?ua=1.
38. Caminero, J.A. (2013). Guidelines for Clinical and Operational Management of Drug-Resistant Tuberculosis, International Union Against Tuberculosis and Lung Disease.
40. Bilateral cavitary multidrug- or extensively drug-resistant tuberculosis: Role of surgery
10.1093/ejcts/ezx350 ↗42. Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment
10.1136/thorax.55.1.32 ↗43. Migliori, G.B., Bothamley, G., Duarte, R., and Rendon, A. (2018). Sequelae Assessment and Rehabilitation. Tuberculosis (ERSMonograph), European Respiratory Society.
10.1183/2312508X.erm8218 ↗46. ATS/ERS Task Force on Pulmonary Rehabilitation. An official American Thoracic Society/European Respiratory Society statement: Key concepts and advances in pulmonary rehabilitation
10.1164/rccm.201309-1634ST ↗48. Respiratory rehabilitation in severe restrictive lung disease secondary to tuberculosis
49. Vibration massage in the prevention of postresection complications and in the clinical rehabilitation of patients with pulmonary tuberculosis after surgical interventions
50. Post-tuberculosis health-related quality of life, lung function and exercise capacity in a cured pulmonary tuberculosis population in the Breede Valley District, South Africa
10.4102/sajp.v75i1.1319 ↗51. Effects of pulmonary rehabilitation in patients with pulmonary tuberculosis sequelae
52. A pre-post intervention study of pulmonary rehabilitation for adults with post-tuberculosis lung disease in Uganda
10.2147/COPD.S146659 ↗54. Pulmonary Rehabilitation in Patients with Chronic Lung Impairment from Pulmonary Tuberculosis
57. Efecto de la rehabilitación pulmonar en la calidad de vida y la capacidad funcional en pacientes con secuelas de tuberculosis [Effect of pulmonary rehabilitation in quality of life and functional capacity in patients with tuberculosis sequela]
10.22490/24629448.1716 ↗58. Pulmonary rehabilitation on aerobic capacity and health-related quality of life in patients with sequelae of pulmonary TB
59. Visca, D., Centis, R., D’Ambrosio, L., Muñoz-Torrico, M., Chakaya, J.M., Tiberi, S., Spanevello, A., Sotgiu, G., and Migliori, G.B. (2020). Post-TB treatment pulmonary rehabilitation: Do we need more?. Int. J. Tuberc. Lung. Dis., in press.